Prospective study for correlation between disease progression and detection of T790M in plasma DNA using MBP-QP method in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

Not Applicable

• Conditions: on-small cell lung cancer

• Registration Number: JPRN-UMIN000005131
• Lead Sponsor: Foundation for Biomedical Research and Innovation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-03-01
• Study Completion: 2014-01-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

1.Non-small cell lung cancer patients with EGFR mutations which is related with acquired resistance such as T790M. 2.Non-small cell lung cancer patients who is not appropriated for the study determined by physician in charge.

Study & Design

• Study Type: Observational
• Study Design: Not specified